COVID-19: WHO reports record daily global case increase as known infections pass 8.9m


Concerns that Donald Trump’s inner circle might pressure the Food and Drug Administration (FDA) to rush a coronavirus vaccine to market in time for the presidential election have risen after the White House attacked the agency for reversing itself on an experimental drug treatment.

Critics say that the FDA’s decision in April to approve hydroxychloroquine for emergency use – an approval that the agency revoked last Monday – demonstrated that the regulator is vulnerable to political pressure from the White House.

But other outside experts said that regulatory approval for any vaccine would require a degree of data transparency that would prevent the process from being unduly rushed.

Read more…
Source:  The Guardian